Guests: John Holaday RSS

In topics:

Tagged with keywords:

1998:

  1. A discussion about the advancements in cancer research
    A discussion about the advancements in cancer research

    with Joseph Bertino, Michael Waldholz and John Holaday on May 5, 1998

    Duration
    13 min
    Comments
    Rating
    * * * *

Dr. John Holaday is the co-founder and Chairman of HarVest Bank of Maryland. He is the founder of EntreMed, Inc. and served as its Chairman, President and Chief Executive Officer and a Director until his retirement in 2003. EntreMed, (ENMD, NASDAQ) is a pioneering antiangiogenesis company that emphasizes therapeutics to inhibit blood vessel growth in cancer, blindness and heart disease.

Dr. Holaday is also the co-founder of Medicis Pharmaceutical Corp. (MRX, NYSE) where he served as the SVP for R&D and Member of the Board of Directors. He also founded MaxCyte, Inc. where he served as Chairman, and as a member of the Board of Directors of CytImmune Sciences, BSI Proteomics, Rexahn and LabBook. He has raised over $300M in private and public rounds of financing for these companies that have a collective market capitalization in excess of $3B US.

Dr. Holaday holds over 30 U.S. and foreign patents and has published over 200 scientific articles and reviews, and edited five books.

Source-Biosciences Business IG http://www3.cancer.gov/bbig/Holaday2004.html